Pharmacielo Ltd (PCLO.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 1,265 | 1,414 | 1,579 | 1,256 | 1,566 |
| Accounts receivable | -131 | 421 | -400 | 125 | -1,986 |
| Other Working Capital | 794 | 2,217 | -1,623 | -7,576 | 3,308 |
| Other Operating Activity | -3,897 | -9,202 | -9,264 | -13,879 | -25,453 |
| Operating Cash Flow | $-1,969 | $-5,150 | $-9,708 | $-20,073 | $-22,564 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 41 | 213 | -522 | -1,138 | -5,434 |
| Net Acquisitions | N/A | N/A | 0 | -1,296 | -1,040 |
| Purchase Of Investment | N/A | 0 | -204 | 0 | -500 |
| Sale Of Investment | 0 | 179 | 0 | 777 | 1,402 |
| Investing Cash Flow | $41 | $392 | $-725 | $-1,657 | $-5,572 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -474 | -519 | -319 | -79 | N/A |
| Debt Issued | 985 | 5,445 | 5,795 | 5,000 | 3,152 |
| Debt Repayment | -42 | -298 | -303 | -308 | -261 |
| Common Stock Issued | N/A | N/A | 0 | 13,549 | 20,361 |
| Other Financing Activity | 1,550 | 0 | 123 | 47 | 71 |
| Financing Cash Flow | $2,019 | $4,628 | $5,296 | $18,209 | $23,322 |
| Exchange Rate Effect | -5 | 19 | -28 | N/A | N/A |
| Beginning Cash Position | 62 | 173 | 5,338 | 8,860 | 13,673 |
| End Cash Position | 148 | 62 | 173 | 5,338 | 8,860 |
| Net Cash Flow | $91 | $-130 | $-5,137 | $-3,521 | $-4,814 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,969 | -5,150 | -9,708 | -20,073 | -22,564 |
| Capital Expenditure | N/A | -15 | -522 | -1,138 | -5,434 |
| Free Cash Flow | -1,969 | -5,165 | -10,230 | -21,211 | -27,998 |